Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.
Financial Results:
Sanofi India Ltd reported Revenues for Q4FY24 of ₹732.00 Crores down from ₹736.00 Crore year on year, a fall of 0.54%.
Total Expenses for Q4FY24 of ₹524.00 Crores up from ₹517.00 Crores year on year, a rise of 1.35%.
Consolidated Net Profit of ₹137.00 Crores down 27.89% from ₹190.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹59.31, down 28.26% from ₹82.67 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.